Corcept Therapeutics (CORT) EBITDA Margin (2012 - 2026)
Corcept Therapeutics (CORT) recorded EBITDA Margin of 34.00% in Q3 2026, up 28.85 percentage points from 5.15% a year earlier and up 17.54 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) EBITDA Margin (2012 - 2026) Analysis & Trends
On a TTM basis, Corcept Therapeutics' EBITDA Margin came in at 11.74% as of Sep 30, 2026, up 2.67 percentage points year-over-year; for FY2025, it came in at 6.03%, down 14.37 percentage points from FY2024.
- Annual EBITDA Margin has declined for six straight years, with a five-year change of -30.34 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 20.41% in FY2024 (-2.15 pp), 22.55% in FY2023 (-5.91 pp), 28.46% in FY2022 (-5.96 pp) and 34.42% in FY2021 (-1.96 pp).
- The Q3 2026 figure is the highest quarterly EBITDA Margin since Q4 2021.
- On a year-over-year basis, EBITDA Margin rose in two of the last eight quarters, with an average year-over-year change of -8.55 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 28.85 percentage points in Q3 2026, against a drop of 32.18 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 16.46% (Q2 2026), -29.72% (Q1 2026) and 2.09% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 42.49% |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 34.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.00% |
| Jun 30, 2026 | 16.46% |
| Mar 31, 2026 | -29.72% |
| Dec 31, 2025 | 2.36% |
| Sep 30, 2025 | 4.89% |
| Jun 30, 2025 | 13.96% |
| Mar 31, 2025 | 2.47% |
| Dec 31, 2024 | 14.04% |
| Sep 30, 2024 | 25.70% |
| Jun 30, 2024 | 21.78% |
| Mar 31, 2024 | 20.21% |
| Dec 31, 2023 | 23.55% |
| Sep 30, 2023 | 25.41% |
| Jun 30, 2023 | 25.49% |
| Mar 31, 2023 | 14.33% |
| Dec 31, 2022 | 22.47% |
| Sep 30, 2022 | 31.58% |
| Jun 30, 2022 | 30.51% |
| Mar 31, 2022 | 28.88% |
| Dec 31, 2021 | 37.39% |
API Access
Corcept Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();